Search Legislation

The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)
 Help about opening options

Opening OptionsExpand opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendment of regulation 22

This section has no associated Explanatory Memorandum

8.  After regulation 22(1) (factors relevant to determination of application for manufacturer’s or wholesale dealer’s licence) insert—

(1A) In dealing with an application for a manufacturer’s licence (MM) the licensing authority must, in addition to the matters specified in paragraph (1), take into consideration the arrangements made, or to be made, for—

(a)supervising and controlling operations at a modular unit specified in the application; and

(b)ensuring that manufacture or assembly is under appropriate control so that the MM medicinal product consistently meets the requirements in the MM master file when manufactured at that modular unit.

(1B) In dealing with an application for a manufacturer’s licence (POC) the licensing authority must, in addition to the matters specified in paragraph (1), take into consideration the arrangements made, or to be made, for—

(a)supervising and controlling operations at a POC site specified in the application; and

(b)ensuring that manufacture or assembly is under appropriate control so that the POC medicinal product consistently satisfies the requirements in the POC master file when manufactured at that POC site..

Back to top

Options/Help